Key Account Manager

Why Cor Medix Therapeutics?

If you are interested in joining an entrepreneurial team focused on bringing life‑saving therapies to market for critical unmet medical needs, consider applying for a role at Cor Medix Therapeutics. The culture at Cor Medix Therapeutics is patient‑centered, with a sense of urgency to solve the most pressing issues in hospital‑based healthcare. Cor Medix’s greatest asset is our people. We have a deeply experienced team and continue to bring on some of the brightest talent that can problem‑solve and execute with high precision.

We are passionate about the work we do and how we do it. We believe in building highly engaged teams that exude integrity, open communication, and innovation. We foster each employee to reach their highest potential by offering an inclusive environment, opportunities to challenge yourself and grow, and a community of purpose. We expect that everyone brings their best selves to work, and together, our singular efforts culminate into profound and meaningful breakthroughs.

Cor Medix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life‑threatening conditions and diseases in the United States. Cor Medix is focused on selling and marketing products in institutional settings of care in the US and has field‑based medical and commercial infrastructure deployed in hospitals, clinics and infusion centers. Rezafungin is currently approved for the treatment of candidemia and invasive candidiasis in adults.

For more information, visit

The Key Account Manager (KAM) is a hospital‑based or integrated sites of care‑based position focused on launching and selling innovative products in assigned institutional accounts, including integrated delivery networks (IDNs) and alternate sites of care for infusion. The role includes educating clinicians on the clinical benefits of Cor Medix Therapeutics products to facilitate and gain improved institutional formulary access and expanding appropriate product utilization through protocol adoption, to exceed business and customer objectives with assigned hospitals and IDNs.

The KAM also has accountability for pulling through contracts and facilitating account and clinician access opportunities to ensure achievement of Cor Medix Therapeutics’ business goals. KAMs follow the hospitalized patient journey and call Long‑Term Acute Care hospitals and home infusion companies if necessary in their territories. Some products require the KAM to call on infusion centers outside the hospital, open sites of care outside a hospital for infusion, and call on customers that refer into those infusion centers.

This role manages key accounts across the Hoboken, NJ territory.

• Increase product access and sales in the geographical area by navigating the institutional formulary approval process, as well as educating customers on appropriate use of Cor Medix Therapeutics products.
• Secure placement of Cor Medix Therapeutics’ products on appropriate account protocols and ensure products are in the EMR systems.
• Develop relationships with local infusion sites, LTACHs and home infusion companies.
• Develop territory and account‑level plans to grow product utilization, formulary access, and expand the customer base.
• Understand multiple interdependencies within an account, consider customer treatment goals and needs, and maximize account performance by aligning appropriate solutions, messaging, and stakeholders.
• Establish and maintain professional relationships with customer opinion leaders and hospitals, including physicians, medical staff and pharmacies.
• Plan, coordinate, and implement hospital‑oriented education forums in accordance with company policies and business plans.
• Partner with hospital treatment committees to include Cor Medix Therapeutics products on appropriate disease‑state protocols.
• Facilitate continuity of care for discharging patients via Cor Medix Therapeutics product inclusion on discharge protocols/orders and alignment of approved Cor Medix Therapeutics reimbursement resources.
• Collaborate and…